logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Oversubscription equals free schools success?

12 April 2013

The DfE have released figures which show that almost nine out of ten free schools receive more applications than available places. Free schools are state-funded schools set up by parents or other groups, independent of local council control with the aim of responding to demand from local parents.

The DfE have argued that the figures showed “how popular free schools are with parents”. Critics would argue, however, that merely assessing application data fails to take account of the full picture.  The National Union of Teachers have recently reported that new free schools are opening in areas with a surplus of places, consequently damaging existing schools by drawing away pupils and threatening the viability of services.

Whilst the figures are encouraging, they cannot be seen as a full and objective assessment on the impact of free schools which should also take account of the effect of education in the local communities they are established as a whole.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up